Product Code: ETC4471056 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The apheresis market in Australia is experiencing moderate growth driven by the increasing prevalence of chronic diseases, blood disorders, and organ transplantation procedures requiring therapeutic apheresis and blood component collection. Apheresis is a medical procedure that involves the separation and extraction of specific blood components such as plasma, platelets, red blood cells, and white blood cells using automated equipment known as apheresis machines. It is used in the treatment of conditions such as autoimmune disorders, hematologic malignancies, and renal failure to remove harmful substances from the blood, replace deficient components, or collect donor cells for transplantation. With the growing demand for personalized medicine, regenerative therapies, and blood banking services, there is a rising need for advanced apheresis technologies, disposable kits, and operator training in the Australia market. Key players in the market are offering a wide range of apheresis systems, consumables, and clinical support services to healthcare facilities, blood centers, and transplant centers seeking to expand their therapeutic options and improve patient outcomes.
In Australia, the Apheresis Market sees growth propelled by factors such as the increasing prevalence of chronic and autoimmune diseases, advancements in medical technology, and the demand for blood component therapies. Additionally, factors like healthcare infrastructure, regulatory frameworks governing blood donation and transfusion, and research and development in therapeutic apheresis contribute to market expansion and investment in apheresis technologies.
Challenges in the Australia apheresis market include patient access, reimbursement policies, and technological advancements. Apheresis is a medical procedure involving the separation and removal of blood components for therapeutic purposes. However, ensuring equitable access to apheresis treatments, navigating reimbursement challenges, and adopting innovative technologies pose challenges for healthcare providers and patients in Australia.
In the Australia apheresis market, government regulations prioritize patient safety, blood product quality, and healthcare standards. Standards may encompass procedures for apheresis device operation, donor eligibility criteria, and blood component processing to ensure compliance with regulatory requirements and accreditation standards for blood centers and healthcare facilities. Additionally, regulations may address issues such as adverse event reporting, transfusion-transmitted infection prevention, and quality management systems to maintain the safety and effectiveness of apheresis procedures and blood products. Government agencies provide oversight, accreditation services, and regulatory enforcement to blood establishments, healthcare providers, and regulatory authorities to ensure compliance with apheresis regulations and uphold blood safety standards in Australia.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Apheresis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Apheresis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Apheresis Market - Industry Life Cycle |
3.4 Australia Apheresis Market - Porter's Five Forces |
3.5 Australia Apheresis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Apheresis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 Australia Apheresis Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Australia Apheresis Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.9 Australia Apheresis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Apheresis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring apheresis treatment |
4.2.2 Technological advancements in apheresis procedures and equipment |
4.2.3 Growing awareness about the benefits of apheresis therapies among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 High cost associated with apheresis procedures and equipment |
4.3.2 Limited reimbursement policies for apheresis therapies |
4.3.3 Stringent regulatory requirements for apheresis devices and procedures |
5 Australia Apheresis Market Trends |
6 Australia Apheresis Market, By Types |
6.1 Australia Apheresis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Apheresis Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Australia Apheresis Market Revenues & Volume, By Devices, 2021-2031F |
6.1.4 Australia Apheresis Market Revenues & Volume, By Disposable and Reagents, 2021-2031F |
6.1.5 Australia Apheresis Market Revenues & Volume, By Software, 2021-2031F |
6.2 Australia Apheresis Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 Australia Apheresis Market Revenues & Volume, By Centrifugation, 2021-2031F |
6.2.3 Australia Apheresis Market Revenues & Volume, By Membrane Separation, 2021-2031F |
6.2.4 Australia Apheresis Market Revenues & Volume, By Selective Adsorption, 2021-2031F |
6.3 Australia Apheresis Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Australia Apheresis Market Revenues & Volume, By Donor/Automated Apheresis, 2021-2031F |
6.3.3 Australia Apheresis Market Revenues & Volume, By Therapeutic Apheresis, 2021-2031F |
6.4 Australia Apheresis Market, By Component |
6.4.1 Overview and Analysis |
6.4.2 Australia Apheresis Market Revenues & Volume, By Plasma (Plasmapheresis), 2021-2031F |
6.4.3 Australia Apheresis Market Revenues & Volume, By Platelets (Plateletpheresis), 2021-2031F |
6.4.4 Australia Apheresis Market Revenues & Volume, By Leukocytes (Leukapheresis or leukopheresis), 2021-2031F |
6.4.5 Australia Apheresis Market Revenues & Volume, By Lymphocytes (Lymphopheresis or lymphapheresis), 2021-2031F |
6.4.6 Australia Apheresis Market Revenues & Volume, By RBC's (Erythropheresis), 2021-2031F |
6.5 Australia Apheresis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Australia Apheresis Market Revenues & Volume, By Blood Centers, 2021-2031F |
6.5.3 Australia Apheresis Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.4 Australia Apheresis Market Revenues & Volume, By Other End Users, 2021-2031F |
7 Australia Apheresis Market Import-Export Trade Statistics |
7.1 Australia Apheresis Market Export to Major Countries |
7.2 Australia Apheresis Market Imports from Major Countries |
8 Australia Apheresis Market Key Performance Indicators |
8.1 Average treatment time per patient |
8.2 Percentage of patients opting for repeat apheresis therapies |
8.3 Number of clinical trials incorporating apheresis treatments |
9 Australia Apheresis Market - Opportunity Assessment |
9.1 Australia Apheresis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Apheresis Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 Australia Apheresis Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Australia Apheresis Market Opportunity Assessment, By Component, 2021 & 2031F |
9.5 Australia Apheresis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Apheresis Market - Competitive Landscape |
10.1 Australia Apheresis Market Revenue Share, By Companies, 2024 |
10.2 Australia Apheresis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |